B
Barbara J. Stoll
Researcher at University of Texas Health Science Center at Houston
Publications - 406
Citations - 47301
Barbara J. Stoll is an academic researcher from University of Texas Health Science Center at Houston. The author has contributed to research in topics: Low birth weight & Gestational age. The author has an hindex of 100, co-authored 390 publications receiving 42107 citations. Previous affiliations of Barbara J. Stoll include Emory University Hospital Midtown & Emory University.
Papers
More filters
Journal ArticleDOI
Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants
William Oh,Jon E. Tyson,Avroy A. Fanaroff,Betty R. Vohr,Rebecca Perritt,Barbara J. Stoll,Richard A. Ehrenkranz,Waldemar A. Carlo,Seetha Shankaran,Kenneth Poole,Linda L. Wright +10 more
TL;DR: PSB concentrations during the first 2 weeks of life are directly correlated with death or NDI, hearing impairment, and PDI <70 in ELBW infants, and a randomized, controlled trial of aggressive and conservative phototherapy is needed to address this controversial issue.
Journal ArticleDOI
Prevention of nosocomial infections in the neonatal intensive care unit
TL;DR: Effective strategies to prevent nosocomial infection must include continuous monitoring and surveillance of infection rates and distribution of pathogens; strategic nursery design and staffing; emphasis on handwashing compliance; minimizing central venous catheter use and contamination, and prudent use of antimicrobial agents.
Journal ArticleDOI
Adverse Neonatal Outcomes Associated With Antenatal Dexamethasone Versus Antenatal Betamethasone
TL;DR: Betamethasone was associated with a reduced risk for neonatal death, with trends of decreased risk for other adverse neonatal outcomes, compared with dexamethAsone, and it may be in the best interest of neonates to receive betameth asone rather than dexamETHasone when available.
BookDOI
Improving Birth Outcomes: Meeting the Challenge in the Developing World
TL;DR: Factor in the increased challenges of serving the Medicaid population, which is generally sicker with more behavioral issues and psychosocial barriers than the commercial population, and the complexities and costs rise exponentially.
Journal ArticleDOI
Decline in Sepsis-associated Neonatal and Infant Deaths in the United States, 1979 Through 1994
TL;DR: Despite declines in the overall sepsis-related mortality among newborns, racial and regional gaps in mortality persisted over the 16-year study period, and future efforts to reduce the incidence of sepsi-associated deaths will depend on targeting higher risk populations and reducing prematurity.